TG4-155
CAS: 1164462-05-8
Ref. 3D-PWB46205
2mg | A consultar | |
5mg | A consultar | |
10mg | A consultar | |
25mg | A consultar | |
50mg | A consultar |
Información del producto
TG4-155 is a low potency antiplatelet drug that is a selective antagonist for the prostacyclin receptor. It was initially developed to treat cancer, as it inhibits tumor growth and induces apoptosis in cancer cells. TG4-155 has been shown to be effective in vivo models of breast, prostate, and colon cancers. TG4-155 was also shown to reduce platelet aggregation in primary cells from ovaries and other tissues.
Propiedades químicas
Consulta técnica sobre: 3D-PWB46205 TG4-155
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.